CHICAGO / NEW YORK (Reuters) – Approximately one-fifth of the 11,000 people enrolled in a 30,000-volunteer U.S. trial of a Pfizer COVID-19 vaccine (PFE.N) and German partner BioNTech (22UAy.F) are Black as Latino, groups among the hardest hit by the coronavirus virus pandemic, said a top Pfizer executive. PHILO PHOTO: …
Read More »
FILE PHOTO: A man walks past a sign outside Pfizer headquarters in the source of Manhattan in New York City, New York, USA, July 22, 2020. REUTERS / Carlo Allegri / File Photo (Reuters) – Shares of Pfizer Inc and US-listed shares of partner BioNTech SE rose on Friday after …
Read More »
Russia said Thursday that its coronavirus vaccine, the first to be registered worldwide, will be tested on more than 40,000 people if it appears to increase production. The vaccine, called “Sputnik V”, has received skepticism from international observers about its potential effectiveness, in particular the rapid pace of its approval, …
Read More »
LONDON (Reuters) – Russia’s plan to roll out its “Sputnik-V” COVID-19 vaccine, even before full studies show how well it works, requires concern among virus experts, who warn of a partially effective shot at the new encourage coronavirus to mutate. PHILO PHOTO: A handout photo provided by the Russian Direct …
Read More »
(Reuters) – A US government program that compensates people who say they are harmed by an emergency vaccine has paid out on less than 10% of claims, raising questions about whether the process should be used to deal with any side effects from a coronavirus shot to sue, according to …
Read More »